In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding

Research output: Contribution to journal › Comment/debate

ASJC Scopus subject areas

@article{14083c4b02794cda92f000817d1d868d,

title = "In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding",

author = "Elgendy, \{Islam Y.\}",

year = "2020",

month = sep,

day = "15",

doi = "10.7326/ACPJ202009150-027",

language = "English",

volume = "173",

pages = "JC27",

number = "6",

}

TY - JOUR

T1 - In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding

AU - Elgendy, Islam Y.

PY - 2020/9/15

Y1 - 2020/9/15

UR - http://www.scopus.com/inward/record.url?scp=85091051266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091051266&partnerID=8YFLogxK

U2 - 10.7326/ACPJ202009150-027

DO - 10.7326/ACPJ202009150-027

M3 - Comment/debate

C2 - 32926820

AN - SCOPUS:85091051266

SN - 0003-4819

VL - 173

SP - JC27

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 6

ER -